Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality

Details for Australian Patent Application No. 2004296790 (hide)

Owner Forest Laboratories, Inc.

Inventors Flicker, Charles; Hakkarainen, Heikki; McDonald, Scott

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004296790

PCT Pub. Number WO2005/055996

Priority 60/527,268 05.12.03 US

Filing date 3 December 2004

Wipo publication date 23 June 2005

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/055996 Priority application(s): WO2005/055996

5 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296792-Intelligent medical vigilance system

2004296787-Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin